CSL LimitedASX: CSL

IDELVION(R) (rFIX-FP) - CHMP recommendation

· Issued by CSL Limited

Filed with ASX · · 2 pages · English

® ® ® IX (Recombinant), Albumin Fusion Protein) for patients with haemophilia B. IDELVION is CSL Behring’s long-acting fusion protein, linking recombinant coagulation factor IX ® with recombinant albumin. IDELVION was designated as an orphan medicinal product in 2010 by the European Commission. ® “CHMP’s positive opinion for IDELVION moves us one step closer to bringing this long- acting treatment

CSL Limited on 6ix

Earlier from CSL

Later from CSL

All CSL news releases